Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

348 ARTÍCULOS , VIENDO DEL 241 AL 255

Retinal nerve fibre layer thickness changes in Alzheimer's disease: Results from a 12-month prospective case series

Trebbastoni A, D'Antonio F, Bruscolini A, Marcelli M, Cecere M, Campanelli A, Imbriano L, de Lena C, Gharbiya M.

Neurosci Lett. 2016 Aug 26;629:165-170. doi: 10.1016/j.neulet.2016.07.006. Epub 2016 Jul 6.

The Need for Early Detection and Treatment in Alzheimer's Disease

EBioMedicine. 2016 Jul;9:1-2. doi: 10.1016/j.ebiom.2016.07.001. Epub 2016 Jul 5.

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

Chiasserini D, Biscetti L, Farotti L, Eusebi P, Salvadori N, Lisetti V, Baschieri F, Chipi E, Frattini G, Stoops E, Vanderstichele H, Calabresi P, Parnetti L.

J Alzheimers Dis. 2016 Jul 22;54(1):55-67. doi: 10.3233/JAD-160298.

A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease

Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ.

J Alzheimers Dis. 2016 Jul 22;54(1):223-32. doi: 10.3233/JAD-160544.

Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data

Pagani M, Giuliani A, Öberg J, Chincarini A, Morbelli S, Brugnolo A, Arnaldi D, Picco A, Bauckneht M, Buschiazzo A, Sambuceti G, Nobili F.

Neuroimage. 2016 Nov 1;141:282-290. doi: 10.1016/j.neuroimage.2016.07.043. Epub 2016 Jul 22.

Alzheimer's disease: presence and role of microRNAs

Basavaraju M, de Lencastre A.

Biomol Concepts. 2016 Aug 1;7(4):241-52. doi: 10.1515/bmc-2016-0014.

Applied multimodal diagnostics in a case of presenile dementia

Schönecker S, Brendel M, Huber M, Vollmar C, Huppertz HJ, Teipel S, Okamura N, Levin J, Rominger A, Danek A.

BMC Neurol. 2016 Aug 9;16:131. doi: 10.1186/s12883-016-0647-7.

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty

Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Yu Z.

Mol Med Rep. 2016 Oct;14(4):3184-98. doi: 10.3892/mmr.2016.5618. Epub 2016 Aug 9.

A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease

Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio R.

J Mol Neurosci. 2016 Nov;60(3):354-361. doi: 10.1007/s12031-016-0810-z. Epub 2016 Aug 11.

Searching biomarkers for mental disorders-lessons from Alzheimer's disease

Maier W.

Eur Arch Psychiatry Clin Neurosci. 2016 Oct;266(7):583-5. doi: 10.1007/s00406-016-0732-3.

[Clinical Implications and Appropriate Use of Amyloid Imaging with florbetapir ((18)F) in Diagnosis of Patients with Alzheimer Disease]

Nakamura T, Iwata A, Ueda K, Namiki C.

Brain Nerve. 2016 Oct;68(10):1215-1222. doi: 10.11477/mf.1416200578.

Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics

Hickman RA, Faustin A, Wisniewski T.

Neurol Clin. 2016 Nov;34(4):941-953. doi: 10.1016/j.ncl.2016.06.009. Epub 2016 Aug 4.

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease

Brody M, Liu E, Di J, Lu M, Margolin RA, Werth JL, Booth K, Shadman A, Brashear HR, Novak G.

J Alzheimers Dis. 2016 Oct 18;54(4):1509-1519. doi: 10.3233/JAD-160369.

Alzheimer disease: Biomarkers of AD risk - the end of the road for plasma amyloid-β?

Wood H.

Nat Rev Neurol. 2016 Nov;12(11):613. doi: 10.1038/nrneurol.2016.160. Epub 2016 Oct 14.

Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease

Kulic L, Unschuld PG.

Curr Opin Neurol. 2016 Dec;29(6):749-755. doi: 10.1097/WCO.0000000000000399.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias